Retatrutide (LY3437943) is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously that has not received UK marketing authorisation from the MHRA or approval from the EMA
Digestive-comfort strains Bifidobacterium lactis is the standout for regularity, showing the clearest benefit for constipation and gut transit time in the meta-analysis data [9] , directly relevant to the most common GLP-1 complaint
The maintenance reality after Retatrutide is challenging
For example, the elevated IOP in glaucoma eyes exerts mechanical stress at the optic nerve head, a key site for RGC damage, and leads to neurodegeneration and visual impairment
Including fish in the diet is an excellent way to increase L-carnitine intake while also providing other nutrients important for cardiovascular health and brain function
5.2.2 Topiramate as an anti-inflammatory agent Topiramate has demonstrated neuroprotective effects in various pathological models, particularly through its anti-inflammatory properties